Feldman S, Bisno A L, Lott L, Dodge R, Jackson R E
J Pediatr. 1987 May;110(5):783-7. doi: 10.1016/s0022-3476(87)80024-0.
The rate of streptococcal eradication after intramuscular administration of benzathine penicillin G in 66 children with acute group A streptococcal pharyngitis was determined and possible reasons for treatment failure explored. Bacteriologic treatment failure, defined as isolation of the same serotype at 3- or 6-weeks follow-up, occurred in eight (12%) patients. The treatment failure rate was 21% in those with immunologically significant infection, versus 8% in those without antibody rises (P greater than 0.1). All group A beta-hemolytic streptococcal (GABS) strains isolated from patients with treatment failure, both before and after benzathine penicillin G therapy, were exquisitely susceptible to penicillin G (minimum inhibitory concentration less than or equal to 0.02 microgram/mL), and none showed evidence of tolerance (minimum bactericidal concentration less than or equal to 0.04 microgram/mL). Thus, we found GABS eradication rates to exceed 10% in children given benzathine penicillin G. The failure rate did not appear to be related to enrichment of the patient population with a high proportion of asymptomatic carriers nor to the presence of penicillin-tolerant GABS.
测定了66例患有急性A组链球菌性咽炎的儿童肌内注射苄星青霉素G后的链球菌清除率,并探讨了治疗失败的可能原因。细菌学治疗失败定义为在3周或6周随访时分离出相同血清型,8例(12%)患者出现治疗失败。免疫反应显著感染患者的治疗失败率为21%,抗体未升高患者的治疗失败率为8%(P>0.1)。从治疗失败患者中分离出的所有A组β溶血性链球菌(GABS)菌株,在苄星青霉素G治疗前后,对青霉素G均高度敏感(最低抑菌浓度≤0.02微克/毫升),且均未显示出耐药迹象(最低杀菌浓度≤0.04微克/毫升)。因此,我们发现给予苄星青霉素G的儿童中GABS清除率超过10%。失败率似乎与无症状携带者比例高的患者群体富集无关,也与耐青霉素GABS的存在无关。